| 摘要 |
The present invention concerns a quantititive in situ assessment of mean telomere length, particularly in relation to nuclear area, for the diagnosis and/or prognosis of cancer. In particular aspects, the methods and compositions regard diagnosis and/or prognosis of bladder cancer, urothelial cancer, lung cancer, and lymphoma.
|
| 申请人 |
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM;KATZ, RUTH, L.;GU, JUN;KHANNA, ABHA;FERNANDEZ, RICARDO |
发明人 |
KATZ, RUTH, L.;GU, JUN;KHANNA, ABHA;FERNANDEZ, RICARDO |
